Skip to main content
Log in

Kinetics of ceftazidime during plasmapheresis

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The influence of plasmapheresis (PA) on the elimination kinetics of ceftazidime (Cef) has been investigated. A single dose of Cef was administered intravenously to 11 patients with autoimmune diseases and varying degrees of renal impairment (Group I CLCR<50 ml/min, Group II CLCR>50 ml/min).

In Groups I and II the mean total clearance of Cef (CL) was 30 and 116 ml/min−1, respectively. The elimination half-life (t1\2β) and the volume of distribution (V) were significantly higher in Group I than in Group II (11.9 vs 2.0 h, 27.1 vs 18.5 l). PA had no influence on the plasma level-time profile of Cef. The amount of Cef recovered from separated plasma accounted for only 2 to 9% of the administered dose, being particularly low in patients with normal renal function (4.6%).

Thus, since elimination of Cef via PA is negligible, dosage calculations should be based solely on renal function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arsac P, Credoz D, Barret L, Faure J (1980) Intoxication digitalique traitee par exchange plasmatique. Nouv Presse Med 9: 3097

    Google Scholar 

  • Brown-Molnar CS, Bauer LA, Horn JR (1986) Phenytoin removal by plasmapheresis in renal insufficiency. Am J Nephrol 6: 302–306

    Google Scholar 

  • Drusano GL, Joshi J, Forrest A, Ruxer R, Standiford H, Leslie J, Wade J, Schimpff S (1985) Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients. Antimicrob Agents Chemother 27: 605–607

    Google Scholar 

  • Garcia MJ, Sominguez-Gil A, Tabernero JM, Molina MD (1983) Pharmacokinetics of cefoxitin during hemofiltration. Eur J Clin Pharmacol 25: 395–398

    Google Scholar 

  • Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd ed. Marcel Dekker, New York, pp 45–128

    Google Scholar 

  • Glöckner WM, Sieberth HG (1978) Plasmafiltration, a new method of plasma exchange. Proc Eur Soc Artif Organs 5: 214–219

    Google Scholar 

  • Gravert C, Schulz E, Sack K (1983) Ceftazidime in intensive care medicine and hemofiltration. J Antimicrob Chemother 12: 177–180

    Google Scholar 

  • Harding SM, Ayrton J, Thornton JE, Hogg MIJ (1981) Pharmacokinetics of ceftazidime in normal subjects. J Antimicrob Chemother 8: 263–272

    Google Scholar 

  • Höffler D, Koeppe P, Williams KJ (1983) Pharmacokinetics of ceftazidime in normal and impaired renal function. J Antimicrob Chemother 12 [Suppl A]: 241–245

    Google Scholar 

  • Keller F, Kreutz G, Vöhringer HF, Offermann G, Distler A (1985) Effect of plasma exchange on the steady-state kinetics of digoxin and digitoxin. Clin Pharmacokinet 10: 514–523

    Google Scholar 

  • Leeder JS, Spino M, Tesoro AM, McLeod SM (1983) High pressure liquid chromatographic analysis of ceftazidime in serum and urine. Antimicrob Agents Chemother 24: 720–724

    Google Scholar 

  • Matzke GR, oConnel MB, Collins AJ, Keshaviar PR (1986) Disposition of vancomycin during hemofiltration. Clin Pharmacol Ther 40: 425–430

    Google Scholar 

  • Narang PK, Hunter JR (1984) Is renal function the only determinant in the elimination of ceftazidime? Rev Infect Dis 6: 732

    Google Scholar 

  • Norrby SR, Burman LA, Linderholm H, Trollfors B (1982) Ceftazidime: Pharmacokinetics in patients and effects on the renal function. J Antimicrob Chemother 10: 199–206

    Google Scholar 

  • Peters U, Risler T, Grabensee B (1980) Digitoxin elimination by plasma separation. In: Sieberth (ed) Plasma exchange. Schattauer, Stuttgart New York, pp 365–368

    Google Scholar 

  • Prince AS, Kliegman R, Phaneuf D, Neu HC (1981) The effect of exchange transfusions on the blood levels of ampicillin and gentamicin in neonates. Infection 9: 2–6

    Google Scholar 

  • Rowland M, Tozer TN (1983) Clinical pharmacokinetics. Lea & Febiger, Philadelphia, pp 293–294

    Google Scholar 

  • Schumak KH, Rock GA (1984) Therapeutic plasma exchange. New Eng J Med 310: 762–770

    Google Scholar 

  • Sieberth HG, Glöckner WM (1980) Separation of cells from plasma in man using hollow fiber membranes of large pore size. In: Borberg H, Reuther B (eds) Plasma exchange therapy. Thieme, Stuttgart New York, pp 20–25

    Google Scholar 

  • Silberstein LE, Shaw LM (1986) Effect of plasma exchange on phenytoin plasma concentration. Ther Drug Monit 8: 172–176

    Google Scholar 

  • Simon C, Malerczyk V, Müller U, Müller G (1972) Zur Pharmakokinetic von Propicillin bei geriatrischen Patienten im Vergleich zu jüngeren Erwachsenen. Dtsch Med Wochenschr 97: 1999–2003

    Google Scholar 

  • Stigelman WH, Henry DH, Talbert RL, Townsend RJ (1984) Removal of prednisone and prednisolone by plasma exchange. Am J Hosp Pharm 41: 1910–1914

    Google Scholar 

  • Thamdrup B, Ostergaard OV, Clausen E (1986) Plasma exchange in the treatment of propoxyphene intoxication. Int J Clin Pharmacol Ther Toxicol 24: 379–380

    Google Scholar 

  • Wittman DH, Schassan HH, Kohler F, Seibert W (1981) Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid. J Antimicrob Chemother 8 [Suppl B]: 293–297

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bozkurt, F., Schollmeyer, P. & Keller, E. Kinetics of ceftazidime during plasmapheresis. Eur J Clin Pharmacol 33, 197–201 (1987). https://doi.org/10.1007/BF00544567

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00544567

Key words

Navigation